BDBM339924 3-(Morpholin-4-yl)propyl 5-{[(3S)-1-[(trans-4-{(1S)-1-[(tert-butoxycarbonyl)amino]-2-fluoroethyl}cyclohexyl)carbonyl]-3-(trans-4-methoxycyclohexyl)-L-prolyl]amino}-1-benzofuran-2-carboxylate::US9758480, 201

SMILES CO[C@H]1CCC(CC1)[C@@H]1CCN([C@@H]1C(=O)Nc1ccc2oc(cc2c1)C(=O)OCC(C)C)C(=O)[C@H]1CC[C@@H](CC1)[C@H](N)CF

InChI Key InChIKey=VRSZNBPXJIQYDM-JJCARRQMSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 339924   

TargetCoagulation factor XI(Homo sapiens (Human))
Sumitomo Dainippon Pharma

US Patent
LigandPNGBDBM339924(3-(Morpholin-4-yl)propyl 5-{[(3S)-1-[(trans-4-{(1S...)
Affinity DataIC50:  4.10E+3nMAssay Description:0.35 μg/mL human FXIa was allowed to react with a substrate and a test compound in a 30 mmol/L HEPES buffer solution (pH 7.4) that contained 145...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent